These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens]. Smirnova NI; Livanova LF; Chekhovskaia GV; Eroshenko GA; Lazovskiĭ IuV; Zakharova TL Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874 [TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139. Favre D; Cryz SJ; Viret JF Infect Immun; 1996 Sep; 64(9):3565-70. PubMed ID: 8751900 [TBL] [Abstract][Full Text] [Related]
5. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa]. Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603 [TBL] [Abstract][Full Text] [Related]
6. [A comparative study of the immunogenicity of a bacterial mass and of the cell membranes of Vibrio cholerae grown in vivo and in vitro]. Lobanov VV; Sukhar' VV; Mazrukho BL; Shestialtynova IS; Khanum'ian TA; Nepomniashchaia NB; Sorokin VM Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):64-7. PubMed ID: 9304333 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139. Kumar S; Ray P; Singh H; Ganguly NK J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286 [TBL] [Abstract][Full Text] [Related]
8. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193 [No Abstract] [Full Text] [Related]
9. Cross-reaction between a strain of Vibrio mimicus and V. cholerae O139 Bengal. Ansaruzzaman M; Shimada T; Bhuiyan NA; Nahar S; Alam K; Islam MS; Albert MJ J Med Microbiol; 1999 Sep; 48(9):873-877. PubMed ID: 10482300 [TBL] [Abstract][Full Text] [Related]
10. [The immunobiological properties of the antigenic preparations obtained from a vaccinal strain of Klebsiella pneumoniae 204 grown in media of differing compositions]. Miriasova LV; Basnak'ian IA; Egorova NB; Kurbatova EA; Reshilov LN; Krylova AIu; Efimtseva OV; Shagam NL; Salov VF Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):43-6. PubMed ID: 2251890 [TBL] [Abstract][Full Text] [Related]
11. Vibrio cholerae O139 produces a protease which is indistinguishable from the haemagglutinin/protease of Vibrio cholerae O1 and non-O1. Naka A; Yamamoto K; Albert MJ; Honda T FEMS Immunol Med Microbiol; 1995 Apr; 11(2):87-90. PubMed ID: 7640676 [TBL] [Abstract][Full Text] [Related]
13. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897 [TBL] [Abstract][Full Text] [Related]
14. Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen. Attridge SR; Dearlove C; Beyer L; van den Bosch L; Howles A; Hackett J; Morona R; LaBrooy J; Rowley D Infect Immun; 1991 Jul; 59(7):2279-84. PubMed ID: 1711014 [TBL] [Abstract][Full Text] [Related]
15. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens. Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587 [TBL] [Abstract][Full Text] [Related]
16. [The outer membranes of Vibrio cholerae as a potential component in a chemical vaccine]. Markov EIu; Urbanovich LIa; Golubinskiĭ EP; Chernov AB; Karetnikova ES; Ivanova TA; Pakulev NA Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():86-9. PubMed ID: 7771156 [TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar]. Toporkov AV; Zadnova SP; Smirnova NI Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):53-7. PubMed ID: 15773401 [TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262 [TBL] [Abstract][Full Text] [Related]
19. Serological reactivity of humans to a Vibrio cholerae common antigen. Sciortino CV Curr Microbiol; 1998 Apr; 36(4):196-201. PubMed ID: 9537749 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin. Kossaczka Z; Szu SC Glycoconj J; 2000 Jun; 17(6):425-33. PubMed ID: 11294508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]